Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers

Abstract Background The metastatic cascade is a complex and multistep process with many potential barriers. Recently, miR-193a has been reported to be a suppressive miRNA in multiple types of cancers, but its underlying anti-oncogenic activity in non-small cell lung cancers (NSCLC) is not fully eluc...

Full description

Bibliographic Details
Main Authors: Junjie Chen, Shenmeng Gao, Chunjing Wang, Zhonggai Wang, Huxiang Zhang, Kate Huang, Bin Zhou, Haiying Li, Zhijie Yu, Jianbo Wu, Chengshui Chen
Format: Article
Language:English
Published: BMC 2016-11-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13046-016-0450-8
id doaj-1c29705846584c9fa18f5fd0b89e287d
record_format Article
spelling doaj-1c29705846584c9fa18f5fd0b89e287d2020-11-24T21:11:33ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662016-11-0135111510.1186/s13046-016-0450-8Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancersJunjie Chen0Shenmeng Gao1Chunjing Wang2Zhonggai Wang3Huxiang Zhang4Kate Huang5Bin Zhou6Haiying Li7Zhijie Yu8Jianbo Wu9Chengshui Chen10Department of Respiration, The First Affiliated Hospital of Wenzhou Medical UniversityLaboratory of Internal Medicine, The First Affiliated Hospital of Wenzhou Medical UniversitySchool of Laboratory Medicine & School of Life Science, Wenzhou Medical UniversitySchool of Laboratory Medicine & School of Life Science, Wenzhou Medical UniversityPathology Department, The First Affiliated Hospital of Wenzhou Medical UniversityPathology Department, The First Affiliated Hospital of Wenzhou Medical UniversityLaboratory of Internal Medicine, The First Affiliated Hospital of Wenzhou Medical UniversityLaboratory of Internal Medicine, The First Affiliated Hospital of Wenzhou Medical UniversityLaboratory of Internal Medicine, The First Affiliated Hospital of Wenzhou Medical UniversityLaboratory of Internal Medicine, The First Affiliated Hospital of Wenzhou Medical UniversityDepartment of Respiration, The First Affiliated Hospital of Wenzhou Medical UniversityAbstract Background The metastatic cascade is a complex and multistep process with many potential barriers. Recently, miR-193a has been reported to be a suppressive miRNA in multiple types of cancers, but its underlying anti-oncogenic activity in non-small cell lung cancers (NSCLC) is not fully elucidated. Methods The expressions of miR-193a (miR-193a-5p) in human lung cancer tissues and cell lines were detected by real-time PCR. Dual-luciferase reporter assay was used to identify the direct target of miR-193a. Cell proliferation, apoptosis, and metastasis were assessed by CCK-8, flow cytometry, and Transwell assay, respectively. Results The expression of miR-193a in lung cancer tissues was decreased comparing to adjacent non-tumor tissues due to DNA hypermethylation in lung cancer tissues. Ectopic expression of miR-193a inhibited cell proliferation, colony formation, migration, and invasion in A549 and H1299 cells. Moreover, overexpression of miR-193a partially reversed tumor growth factor-β1 (TGF-β1)-induced epithelial-to-mesenchymal transition (EMT) in NSCLC cells. Mechanistically, miR-193a reduced the expression of WT1, which negatively regulated the protein level of E-cadherin, suggesting that miR-193a might prevent EMT via modulating WT1-E-cadherin axis. Importantly, knockdown of WT1 resembled the anti-cancer activity by miR-193a and overexpression of WT1 partially reversed miR-193a-induced anti-cancer activity, indicating that WT1 plays an important role in miR-193a-induced anti-cancer activity. Finally, overexpression of miR-193a decreased the growth of tumor xenografts in mice. Conclusion Collectively, our results have revealed an important role of miR-193a-WT1-E-cadherin axis in metastasis, demonstrated an important molecular cue for EMT, and suggested a therapeutic strategy of restoring miR-193a expression in NSCLC.http://link.springer.com/article/10.1186/s13046-016-0450-8MiR-193aWilm’s tumor-1E-cadherinEpithelial-to-mesenchymal transition
collection DOAJ
language English
format Article
sources DOAJ
author Junjie Chen
Shenmeng Gao
Chunjing Wang
Zhonggai Wang
Huxiang Zhang
Kate Huang
Bin Zhou
Haiying Li
Zhijie Yu
Jianbo Wu
Chengshui Chen
spellingShingle Junjie Chen
Shenmeng Gao
Chunjing Wang
Zhonggai Wang
Huxiang Zhang
Kate Huang
Bin Zhou
Haiying Li
Zhijie Yu
Jianbo Wu
Chengshui Chen
Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers
Journal of Experimental & Clinical Cancer Research
MiR-193a
Wilm’s tumor-1
E-cadherin
Epithelial-to-mesenchymal transition
author_facet Junjie Chen
Shenmeng Gao
Chunjing Wang
Zhonggai Wang
Huxiang Zhang
Kate Huang
Bin Zhou
Haiying Li
Zhijie Yu
Jianbo Wu
Chengshui Chen
author_sort Junjie Chen
title Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers
title_short Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers
title_full Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers
title_fullStr Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers
title_full_unstemmed Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers
title_sort pathologically decreased expression of mir-193a contributes to metastasis by targeting wt1-e-cadherin axis in non-small cell lung cancers
publisher BMC
series Journal of Experimental & Clinical Cancer Research
issn 1756-9966
publishDate 2016-11-01
description Abstract Background The metastatic cascade is a complex and multistep process with many potential barriers. Recently, miR-193a has been reported to be a suppressive miRNA in multiple types of cancers, but its underlying anti-oncogenic activity in non-small cell lung cancers (NSCLC) is not fully elucidated. Methods The expressions of miR-193a (miR-193a-5p) in human lung cancer tissues and cell lines were detected by real-time PCR. Dual-luciferase reporter assay was used to identify the direct target of miR-193a. Cell proliferation, apoptosis, and metastasis were assessed by CCK-8, flow cytometry, and Transwell assay, respectively. Results The expression of miR-193a in lung cancer tissues was decreased comparing to adjacent non-tumor tissues due to DNA hypermethylation in lung cancer tissues. Ectopic expression of miR-193a inhibited cell proliferation, colony formation, migration, and invasion in A549 and H1299 cells. Moreover, overexpression of miR-193a partially reversed tumor growth factor-β1 (TGF-β1)-induced epithelial-to-mesenchymal transition (EMT) in NSCLC cells. Mechanistically, miR-193a reduced the expression of WT1, which negatively regulated the protein level of E-cadherin, suggesting that miR-193a might prevent EMT via modulating WT1-E-cadherin axis. Importantly, knockdown of WT1 resembled the anti-cancer activity by miR-193a and overexpression of WT1 partially reversed miR-193a-induced anti-cancer activity, indicating that WT1 plays an important role in miR-193a-induced anti-cancer activity. Finally, overexpression of miR-193a decreased the growth of tumor xenografts in mice. Conclusion Collectively, our results have revealed an important role of miR-193a-WT1-E-cadherin axis in metastasis, demonstrated an important molecular cue for EMT, and suggested a therapeutic strategy of restoring miR-193a expression in NSCLC.
topic MiR-193a
Wilm’s tumor-1
E-cadherin
Epithelial-to-mesenchymal transition
url http://link.springer.com/article/10.1186/s13046-016-0450-8
work_keys_str_mv AT junjiechen pathologicallydecreasedexpressionofmir193acontributestometastasisbytargetingwt1ecadherinaxisinnonsmallcelllungcancers
AT shenmenggao pathologicallydecreasedexpressionofmir193acontributestometastasisbytargetingwt1ecadherinaxisinnonsmallcelllungcancers
AT chunjingwang pathologicallydecreasedexpressionofmir193acontributestometastasisbytargetingwt1ecadherinaxisinnonsmallcelllungcancers
AT zhonggaiwang pathologicallydecreasedexpressionofmir193acontributestometastasisbytargetingwt1ecadherinaxisinnonsmallcelllungcancers
AT huxiangzhang pathologicallydecreasedexpressionofmir193acontributestometastasisbytargetingwt1ecadherinaxisinnonsmallcelllungcancers
AT katehuang pathologicallydecreasedexpressionofmir193acontributestometastasisbytargetingwt1ecadherinaxisinnonsmallcelllungcancers
AT binzhou pathologicallydecreasedexpressionofmir193acontributestometastasisbytargetingwt1ecadherinaxisinnonsmallcelllungcancers
AT haiyingli pathologicallydecreasedexpressionofmir193acontributestometastasisbytargetingwt1ecadherinaxisinnonsmallcelllungcancers
AT zhijieyu pathologicallydecreasedexpressionofmir193acontributestometastasisbytargetingwt1ecadherinaxisinnonsmallcelllungcancers
AT jianbowu pathologicallydecreasedexpressionofmir193acontributestometastasisbytargetingwt1ecadherinaxisinnonsmallcelllungcancers
AT chengshuichen pathologicallydecreasedexpressionofmir193acontributestometastasisbytargetingwt1ecadherinaxisinnonsmallcelllungcancers
_version_ 1716753095183040512